Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Fellendorf, FT; Hamm, C; Platzer, M; Lenger, M; Dalkner, N; Bengesser, SA; Birner, A; Queissner, R; Sattler, M; Pilz, R; Kapfhammer, HP; Lackner, HK; van, Poppel, M; Reininghaus, E.
[Symptom Monitoring and Detection of Early Warning Signs in Bipolar Episodes Via App - Views of Patients and Relatives on e-Health Need].
Fortschr Neurol Psychiatr. 2022; 90(6):268-279 Doi: 10.1055/a-1503-4986
Web of Science PubMed FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Fellendorf Frederike
Hamm Carlo
Co-Autor*innen der Med Uni Graz
Bengesser Susanne
Birner Armin
Dalkner Nina
Kapfhammer Hans-Peter
Lackner Helmut Karl
Lenger Melanie
Pilz Rene
Platzer Martina
Queissner Robert
Reininghaus Eva
Van Poppel Mireille Nicoline Maria

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

BACKGROUND: The onset and early warning signs of episodes of bipolar disorder are often realized late by those affected. The earlier an incipient episode is treated, the more prognostically favorable the course will be. Symptom monitoring via smartphone application (app) could be an innovative way to recognize and react to early warning signs more swiftly. The aim of this study was to find out whether patients and their relatives consider technical support through an app to be useful and practical in the early warning sign detection and treatment. METHODS: In the present study, 51 patients with bipolar disorder and 28 relatives were interviewed. We gathered information on whether participants were able to perceive early warning signs in form of behavioral changes sufficiently and in a timely fashion and also whether they would use an app as treatment support tool. RESULTS: Although 94.1% of the surveyed patients and 78.6% of their relatives felt that they were well informed about the disease, 13.7% and 35.7%, respectively were not fully satisfied with the current treatment options. Early warning signs of every depressive development were noticed by 25.5% of the patients (relatives 10.7%). Every (hypo)manic development was only noticed by 11.8% of the patients (relatives 7.1%); 88.2% of the patients and 85.7% of the relatives noticed the same symptoms recurrently at the beginning of a depression and 70.6% and 67.9%, respectively, at the beginning of a (hypo)manic episode (in particular changes in physical activity, communication behavior and the sleep-wake rhythm). 84.3% of the patients and 89.3% of the relatives stated that they considered technical support that draws attention to mood and activity changes as useful and that they would use such an app for the treatment. DISCUSSION: The current options for perceiving early warning signs of a depressive or (hypo)manic episode in bipolar disorder are clinically inadequate. Those affected and their relatives desire innovative, technical support. Early detection of symptoms, which often manifest themselves in changes in behavior or activity patterns, is essentiell for managing the course of bipolar disorder. In the future, smartphone apps could be used for clinical treatment and research through objective, continuous and.
Find related publications in this database (using NLM MeSH Indexing)
Bipolar Disorder - diagnosis, drug therapy
Emotions - administration & dosage
Humans - administration & dosage
Mania - administration & dosage
Mobile Applications - administration & dosage
Telemedicine - administration & dosage

Find related publications in this database (Keywords)
mobile health
bipolar disorder
smartphone app
symptom monitoring
early warning signs
© Med Uni Graz Impressum